cercetări histologice şi imunohistochimice în ... - "Gr.T. Popa" Iasi

81. Foxwell D, Gower TK, Douglas-Jones A, Monypenny I, Vaughan-Williams E. A
retrospective review of all screen detected LCIS patients in Wales. EJSO, 2008, 34:1191-1192
82. Fryback GD, Stout KN, Rosenberg AM, Trentham-Dietz A et al. The Wisconsin breast cancer
epidemiology simulation model. J Natl Canc Inst Monogr, 2006, 36:37-47.
83. Giancotti V. Breast cancer markers. Canc Lett, 2006, 243:145-159.
84. Gianni L, Gelber S, Ravioli A, Price NK, Panzini I, Fantini M et al. Second non-breast
primary cancer following adjuvant therapy for early breast cancer: A report from the
International Breast Cancer Study Group. Eur J Cancer, 2009, 45:561-571.
85. Greenwood HL. Mammographic surveillance in the follow up of early primary breast cancer
in England: Across-sectional survey. Radiography, 2008, Epub, 1- 8.
86. Groetelaers RPTGC, Van Berlo CLH, Nijhuis PHA, Schapers RFM, Gerritsen HAM. Axillary
recurrences after negative sentinel lymph node biopsy under local anesthesia for breast cancer:
A follow-up study after 5 years. EJSO, 2009, 35:159-163.
87. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by
immunohistochemistry is superior to the ligand-binding assay for predicting response to
adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17:1474-1481
88. Haitian Z, Yunfei L, Jian L, Qinghua L, Fuqiang W. Mutation screening of the BRCA1 gene
in sporadic breast cancer in southern Chinese populations. Breast, 2008, 17:563-567.
89. Hance WK, Anderson FW, Devesa SS, Young AH. Trends in inflammatory breast carcinoma
incidence and survival: The surveillance, epidemiology and End Results Program at the
National Cancer Institute. J Natl Canc Inst, 2005, 97:966-975.
90. He Q, Jiang J, Yang X, Fan L, Guo M, Zhang Y. A pilot study on thoracoscopic internal
mammary lymphatic chain dissection for breast cancer. Breast, 2008, 17:568-573.
91. Hopper LJ, Chenevix-Trench G, Jolley JD, Dite SG, Jenkins AM, Venter JD, McCredie REM,
Giles GG. Design and analysis issue in a population-based, case-controle-family study of the
genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer
Studies (CFRBCS). J Natl Canc Inst Monographs. 1999, 26:95-100.
92. Huang YW, Newman B, Millikan C, Schell JM, Hulka SB, Moorman GP. Hormone-related
factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor
status. Am J Epidemiol, 2000, 151:703-714.
93. Hughes R, Foulkes R, Jones C, Holland P, Gateley C. Does the diagnostic core biopsy
represent the operative histopathology in invasive breast cancer? EJSO, 2008, 34:1175.
94. Hulvat M, Rajan E, Sarker S, Schermer C, Aranha G, Yao K. Histopathologic characteristics
of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
Surgery, 2008, 144:518-524.
95. Hurria A. Breast cancer: medical management of early stage breast cancer. 9th SIOG Meeting,
October 16 – 18, 2008, Montreal, Canada.
96. Ibrahim AEK, Bateman AC, Theaker JM. The role and histological classification of needle
core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment
of impalpable breast lesion. J Clin Pathol, 2001, 54:121-125.
97. Irvin JWJr, Carey AL. What is triple-negative breast cancer? Eur J Cancer, 2008, 44:2799-
2805.
98. Jayasinghe WU, Boyages J. Tumour location is not an independent prognostic factor for
survival following a diagnosis of breast cancer. Breast, 2009, 18:41-46.
99. Joergensen LE, Gunnarsdottir KA, Lanng C, Moeller S, Rasmussen BB. Multifocality as a
prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative
Group (DBCG) 1996 – 2001. Breast, 2008, 17:587-591.
100. John S, Truran P, Kabir M, Surtees P, Rich A, Iwuchukwu O. Breast cancer in the very young
& very old – a 10-year comparative study. EJSO, 2008, 34:1175.
101. Jones J, Vaughan-Williams E, Gower-Thomas K, Bolt S. The early findings from a
surveillance screening program for women with a family history of breast cancer. EJSO, 2008,
34:1193.
102. Jovenin N, Rallet A, Cutuli B, Costa B et al. Breast cancer in seventy-year of age and older in
the Champagne-Ardenne area: tumor characteristics and management. Crit Rev Oncol
Hematol, 2008, 68:S42.
103. Ju HY, Allred FK, Allred DC, Helferich GW. Genistein stimulates growth of human breast
cancer cells in a novel, postmenopausal animal model with low plasma estradiol
concentrations. Carcinogenesis, 2006, 27:1292-1299.
104. Karabatak M, Ince MC. An expert system for detection of breast cancer based on association
rules and neural network. Expert Syst Appl, 2009, 36:3465- 3469.
28